Skip to main content
. 2022 Sep 7;12(39):25397–25404. doi: 10.1039/d2ra02771b

Fig. 1. RGD-based lipid nanoparticles (RGD-LNP) for targeted mRNA delivery. (a) LNP components are prepared in two phases and combined via microfluidic mixing to form RGD-LNP. (b) RGD-LNP are expected to interact with integrin receptors on the surface of cancer cells.

Fig. 1